(Q34253504)

31 July 2017

title

Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients (English)

1 reference

31 July 2017

0 references

1 reference

A. Canessa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1396726

22 September 2022

V. Del Bono

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1396726

22 September 2022

P. De Leo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1396726

22 September 2022

N. Piersantelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1396726

22 September 2022

A. Terragna

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1396726

22 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1396726

22 September 2022

publication date

1 February 1992

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

11

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

125-130

1 reference

In vitro effects of folate inhibitors on Toxoplasma gondii

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF01967063

Comparative effects of cotrimoxazole (trimethoprim-sulphamethoxazole) and spiramycin in pregnant mice infected with Toxoplasma gondii (Beverley strain).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967063

Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967063

AIDS commentary. Toxoplasmic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967063

Adverse Reactions to Trimethoprim-Sulfamethoxazole in Patients with the Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01967063

Treatment of Toxoplasmosis with Trimethoprim-Sulphamethoxazole

21 January 2018

1 reference

12 December 2020

Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients

1 reference

12 December 2020

Outbreak of central-nervous-system toxoplasmosis in western Europe and North America.

1 reference

12 December 2020

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy

1 reference

12 December 2020

Five drug regimens for treatment of acute toxoplasmosis in squirrel monkeys.

1 reference

12 December 2020

Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome

1 reference

12 December 2020

Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.

1 reference

12 December 2020

Depletion of T-4+ lymphocytes with monoclonal antibody reactivates toxoplasmosis in the central nervous system: a model of superinfection in AIDS

1 reference

12 December 2020

Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy

1 reference

12 December 2020

Assessment of therapy for toxoplasma encephalitis. The TE Study Group

1 reference

12 December 2020

The Effect of Trimethoprim and Sulfamethoxazole on Toxoplasma Gondii in Vitro and in Vivo *

1 reference

12 December 2020

Treating toxoplasmosis

1 reference

12 December 2020

[Acquired toxoplasmosis: a new chemotherapy: the sulfamethoxazole-trimethoprim combination]

1 reference

12 December 2020

An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites

1 reference

12 December 2020

Activity of the combination trimethoprim-sulfamethoxazole on experimental toxoplasmosis

1 reference

12 December 2020

Cutaneous reactions to trimethoprim-sulfamethoxazole in Haitians

1 reference

12 December 2020

Therapeutic future of trimethoprim-sulfamethoxazole in toxoplasmosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01967063

1 reference

Dimensions Publication ID

31 July 2017

1043512032

0 references

1 reference